Kineret® (anakinra) Receives a Positive Opinion from CHMP for the Treatment of Still’s Disease

February 23, 2018

Responsive image

STOCKHOLM, Feb. 23, 2018 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for anakinra for the treatment of Still’s disease. The…

Category: Precious Metals